CU22751A3 - Derivados de ácido quinolon- y naftiridoncarboxílico - Google Patents

Derivados de ácido quinolon- y naftiridoncarboxílico

Info

Publication number
CU22751A3
CU22751A3 CU1995089A CU1995089A CU22751A3 CU 22751 A3 CU22751 A3 CU 22751A3 CU 1995089 A CU1995089 A CU 1995089A CU 1995089 A CU1995089 A CU 1995089A CU 22751 A3 CU22751 A3 CU 22751A3
Authority
CU
Cuba
Prior art keywords
quinolon
acid
derivatives
naftiridoncarboxyl
salts
Prior art date
Application number
CU1995089A
Other languages
English (en)
Inventor
Klaus-Dieter Bremm
Uwe Petersen
Rainer Endermann
Thomas Schenke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CU22751A3 publication Critical patent/CU22751A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)

Abstract

La invención se refiere a nuevos derivados de ácido quinolon- y naftiridoncarboxílico, que están sustituidos en posición-7 por un resto amina bicíclico insaturado dos veces, a sus sales, y a procedimientos para su fabricación así como agentes antibacterianos que los contienen.
CU1995089A 1994-10-04 1995-10-04 Derivados de ácido quinolon- y naftiridoncarboxílico CU22751A3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4435479A DE4435479A1 (de) 1994-10-04 1994-10-04 Chinolon- und Naphthyridoncarbonsäure-Derivate

Publications (1)

Publication Number Publication Date
CU22751A3 true CU22751A3 (es) 2002-02-28

Family

ID=6529941

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1995089A CU22751A3 (es) 1994-10-04 1995-10-04 Derivados de ácido quinolon- y naftiridoncarboxílico

Country Status (40)

Country Link
US (1) US5679689A (es)
EP (1) EP0705828B1 (es)
JP (1) JP3794737B2 (es)
KR (1) KR100371883B1 (es)
CN (1) CN1063747C (es)
AT (1) ATE187171T1 (es)
AU (1) AU697608B2 (es)
BG (1) BG62965B1 (es)
CA (1) CA2159547A1 (es)
CO (1) CO4480031A1 (es)
CU (1) CU22751A3 (es)
CZ (1) CZ291616B6 (es)
DE (2) DE4435479A1 (es)
DK (1) DK0705828T3 (es)
DZ (1) DZ1933A1 (es)
EE (1) EE03443B1 (es)
ES (1) ES2140599T3 (es)
FI (1) FI954680A7 (es)
GR (1) GR3032659T3 (es)
HR (1) HRP950469B1 (es)
HU (1) HUT73429A (es)
IL (2) IL130921A (es)
MA (1) MA23682A1 (es)
MY (1) MY113196A (es)
NO (1) NO307514B1 (es)
NZ (1) NZ280129A (es)
PE (1) PE29698A1 (es)
PL (1) PL182812B1 (es)
PT (1) PT705828E (es)
RO (1) RO115261B1 (es)
RU (1) RU2145604C1 (es)
SG (1) SG38880A1 (es)
SI (1) SI0705828T1 (es)
SK (1) SK280877B6 (es)
SV (1) SV1995000063A (es)
TN (1) TNSN95099A1 (es)
TW (1) TW364908B (es)
UA (1) UA42797C2 (es)
YU (1) YU63595A (es)
ZA (1) ZA958296B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
WO2004083207A1 (en) * 2003-03-12 2004-09-30 Abbott Laboratories Naphthyridine derivatives as antibacterial agents
MX2009007291A (es) 2007-01-05 2009-07-14 Daiichi Sankyo Co Ltd Derivado de aminopirrolidina sustituido fusionado.
US12478621B2 (en) * 2019-11-28 2025-11-25 Deutsches Krebsforschungszentrum Substituted aminoquinolones as dgkalpha inhibitors for immune activation
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
JPH03181478A (ja) * 1989-12-08 1991-08-07 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
JPH04253973A (ja) 1990-04-20 1992-09-09 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
CA2076982A1 (en) * 1990-12-27 1992-06-28 Akira Okura Pyridonecarboxylic acid derivatives
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
PT812838E (pt) * 1994-02-04 2002-10-31 Dainippon Pharmaceutical Co Derivado de acido piridonacarboxilico substituido com o grupo amino biciclico seu ester seu sal e amina biciclica como seu intermediario
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate

Also Published As

Publication number Publication date
ES2140599T3 (es) 2000-03-01
HU9502888D0 (en) 1995-11-28
ATE187171T1 (de) 1999-12-15
HRP950469B1 (en) 2000-12-31
CZ291616B6 (cs) 2003-04-16
IL115492A (en) 1999-12-22
EP0705828B1 (de) 1999-12-01
TNSN95099A1 (fr) 1996-02-06
NO953931D0 (no) 1995-10-03
CN1126211A (zh) 1996-07-10
SI0705828T1 (en) 2000-02-29
CN1063747C (zh) 2001-03-28
ZA958296B (en) 1996-05-07
SK280877B6 (sk) 2000-08-14
SK123895A3 (en) 1996-06-05
DE59507324D1 (de) 2000-01-05
HUT73429A (en) 1996-07-29
EE9500069A (et) 1996-04-15
FI954680L (fi) 1996-04-05
TW364908B (en) 1999-07-21
FI954680A0 (fi) 1995-10-02
UA42797C2 (uk) 2001-11-15
SV1995000063A (es) 1996-07-24
PE29698A1 (es) 1998-08-27
RO115261B1 (ro) 1999-12-30
NZ280129A (en) 1996-06-25
PT705828E (pt) 2000-04-28
AU3291995A (en) 1996-04-18
NO953931L (no) 1996-04-09
RU2145604C1 (ru) 2000-02-20
SG38880A1 (en) 1997-04-17
CZ256895A3 (en) 1996-04-17
BG62965B1 (bg) 2000-12-29
GR3032659T3 (en) 2000-06-30
IL115492A0 (en) 1996-01-19
KR100371883B1 (ko) 2003-03-29
DE4435479A1 (de) 1996-04-11
DZ1933A1 (fr) 2002-02-17
MA23682A1 (fr) 1996-07-01
BG100041A (bg) 1996-05-31
YU63595A (sh) 1998-08-14
EE03443B1 (et) 2001-06-15
US5679689A (en) 1997-10-21
KR960014118A (ko) 1996-05-22
CA2159547A1 (en) 1996-04-05
IL130921A (en) 2001-10-31
FI954680A7 (fi) 1996-04-05
JP3794737B2 (ja) 2006-07-12
MY113196A (en) 2001-12-31
NO307514B1 (no) 2000-04-17
CO4480031A1 (es) 1997-07-09
DK0705828T3 (da) 2000-05-15
EP0705828A1 (de) 1996-04-10
PL182812B1 (pl) 2002-03-29
HRP950469A2 (en) 1997-08-31
JPH08225567A (ja) 1996-09-03
AU697608B2 (en) 1998-10-15
PL310747A1 (en) 1996-04-15

Similar Documents

Publication Publication Date Title
MX9605613A (es) Procedimiento para preparar formas anhidras e hidratadas de derivados de piperidina antihistaminica, polimorfos y pseudomorfos de los mismos.
MX9306023A (es) Acidos quinoloncarboxilicos y procedimiento para su obtencion.
MX9207604A (es) Derivados del acido quinolon-carboxilico y del acido naftiridon-carboxilico y procedimiento para su fabricacion.
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
AR004087A1 (es) Derivado del acido fenilacetico, procedimientos y productos intermedios para su obtencion y las composiciones que los contienen
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
MX9403915A (es) Derivados de n-alquiltio de pliamina como agentes radioprotectores.
MXPA94001345A (es) Derivados de poliamina como agentes radioprotectores.
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
BR9911250A (pt) Processo para preparação de compostos
ES2150461T3 (es) Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes.
SV1995000063A (es) Derivados de acido quinolon- y naftiridoncarboxilico. ref. lea 30 597 -sv
SE9604582D0 (sv) Novel compounds
ES2192263T3 (es) Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas.
ES2156917T3 (es) Proceso para la preparacion de derivados de 1-(4,5-dihidro-2-tiazolil)-3-azetidina-tiol.
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
MX9300306A (es) Bencimidazoles medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
ES2103131T3 (es) Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias.
ECSP951543A (es) Derivados de acido quinolon y maftiridon carboxilico
MX9306178A (es) Bencimidazoles medicamentos que contienen estos compuestos yprocedimientos para su preparacion.
ES2173175T3 (es) Derivado de acido piridonacarboxilico sustituido con un grupo amino biciclico, ester del mismo, sal del mismo, y amina biciclica como intermedio para su preparacion.
ES2177825T3 (es) Procedimiento para la proteccion selectiva de los derivados de la baccatina y su utilizacion en la sintesis de taxanos.
MX9307048A (es) Derivados de piridazinoquinazolona, y composicion farmaceutica que los contiene.